| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |